Renvela
NDC 58468-0131, SEVELAMER CARBONATE, powder, for suspension, from Genzyme Corporation.
- Product NDC
- 58468-0131
- Status
- Listed
- Labeler
- Genzyme Corporation
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022318
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SEVELAMER CARBONATE2400 mg/1
Pharmacologic classes
Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58468-0131-2 | 58468013102 | 90 PACKET in 1 CARTON (58468-0131-2) / 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0131-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e6328460-a57b-450b-a48c-6dcd4b476360
Use it
Look up 58468-0131 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58468-0131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.